International Conference on HIV Treatment and Prevention Adherence

IAPACThe International Association of Providers of AIDS Care (IAPAC) is hosting the 10th annual International Conference on HIV Treatment and Prevention Adherence.

June 28-30, 2015
Eden Roc Miami Beach Hotel, Miami, FL

The conference provides an annual forum for the presentation and discussion of state-of-the-science HIV treatment and biomedical prevention adherence research, as well as current behavioral and clinical perspectives in practicum, within the context of achieving the maximum therapeutic and preventative benefit of antiretroviral therapy across the continuum of care.

Early registration is available until January 9th.

More information can be found on the event page.

Registration will be open through May 8. IAPAC offers reduced rates for your hotel stay, as well as flights through several airlines.

UNC CFAR Investigators Featured at CROI 2015

CROI 2015Five abstracts from UNC CFAR have been accepted for presentation at the poster session at the Conference on Retroviruses and Opportunistic Infections (CROI) 2015, each of which were supported by the UNC CFAR’s Biostatistics Core. This annual collaborative science conference brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2015 will be held from February 23 to February 26, 2015, in Seattle, Washington, at the Washington State Convention Center. Congratulations to all our CFAR investigators for their hard work and dedication!

Poster presentations that will feature UNC CFAR investigators at the conference this year:

Davis N, Miller W, Hudgens M, Chasela C, Sichali D, Nelson J, Rigdon J, Ellington S, Kourtis A, and van der Horst C. ARV adherence associated with reduced breastmilk HIV viral load and HIV transmission. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Jensen K, Van Rompay K, Jacobs W, Fennelly G, Mollan K, Hudgens M, Piatak M, Larsen M, De Paris K. The potential of BCG and HIV-TB vaccines to exacerbate HIV-1 pathogenesis in infants. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Joseph S, Kincer L, Bowman N, Menezes P, Robertson K, Anderson A, Loring D, Eron J, Price R, Swanstrom R. HIV-1 Replication in the CNS is Associated With Increased Neurocognitive Impairment. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

King C, Nelson J, Ziemniak C, Hudgens M, Tegha G, Chasela C, Jamieson D, Persaud D, van der Horst C, Kourtis A. Delayed HIV Detection in Infants Exposed to ARV Prophylaxis During Breastfeeding. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

Nelson J, Fokar A, Hudgens M, Compliment K, Tegha G, Kamwendo D, Kourtis A, Jamieson D, van der Horst C, Fiscus S. NVP Resistance in Infants Infected by HIV-1 via Breastfeeding in the BAN Study. 22nd Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, 2015.

HIV DART 2014: “Frontiers in Drug Development for Antiretroviral Therapies”

HIVDART2014HIV DART 2014 Conference: “Frontiers in Drug Development for Antiretroviral Therapies”

December 9-12, 2014, Los Cabos, Mexico

The focus of HIV DART 2014 is to assemble clinicians, nurses, researchers and basic scientists together to advance our knowledge of the ongoing drug development processes in antiretroviral research. This conference will uniquely blend the areas of biology, chemistry, pharmacology and clinical research to provide the scientific community an increased understanding of the current and future challenges in therapeutics for HIV infection.

For more information, please visit the website.